PAP
Persistent Asset Partners Portfolio holdings
AUM
$114M
This Quarter Return
+9.54%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$114M
AUM Growth
+$114M
(+0.72%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
34.23%
Holding
207
New
51
Increased
27
Reduced
32
Closed
45
Top Buys
| 1 |
Humana
HUM
|
$4.13M |
| 2 |
Soleno Therapeutics
SLNO
|
$3.68M |
| 3 |
Encompass Health
EHC
|
$3.58M |
| 4 |
Amgen
AMGN
|
$3.35M |
| 5 |
Tenet Healthcare
THC
|
$2.2M |
Top Sells
| 1 |
Centene
CNC
|
$10.3M |
| 2 |
UnitedHealth
UNH
|
$4.9M |
| 3 |
iShares Bitcoin Trust
IBIT
|
$3.28M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$2.98M |
| 5 |
CON
Concentra Group Holdings Parent, Inc.
CON
|
$2.39M |
Sector Composition
| 1 | Healthcare | 61.17% |
| 2 | Financials | 18.93% |
| 3 | Materials | 5.9% |
| 4 | Technology | 3.43% |
| 5 | Energy | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Reddit
RDDT
$41.8B
| $452K | 0.34% |
3,000
| – | – |
|
77
Oracle
ORCL
$628B
| $437K | 0.32% |
2,000
| – | – |
|
78
Viridian Therapeutics
VRDN
$1.59B
| $392K | 0.29% |
28,032
-9,179
| -25% | -$128K |
|
79
Merck
MRK
$210B
| $368K | 0.27% |
+4,647
| New | +$368K |
|
80
Pacira BioSciences
PCRX
$1.22B
| $324K | 0.24% |
13,575
+4,612
| +51% | +$110K |
|
|
NPB
81
Northpointe Bancshares, Inc.
NPB
$621M
| $322K | 0.24% |
23,475
-41,721
| -64% | -$572K |
|
82
Towne Bank
TOWN
$2.85B
| $321K | 0.24% |
+9,390
| New | +$321K |
|
83
QCR Holdings
QCRH
$1.32B
| $319K | 0.24% |
4,695
-19,229
| -80% | -$1.31M |
|
84
Ryanair
RYAAY
$32.9B
| $281K | 0.21% |
4,864
-14,084
| -74% | -$812K |
|
85
Zeekr
ZK
$7.39B
| $255K | 0.19% |
+10,000
| New | +$255K |
|
86
Olema Pharmaceuticals
OLMA
$432M
| $248K | 0.18% |
58,333
+35,345
| +154% | +$151K |
|
87
Reviva Pharmaceuticals
RVPH
$31.3M
| $244K | 0.18% |
641,174
+480,864
| +300% | +$183K |
|
88
Orange County Bancorp
OBT
$353M
| $243K | 0.18% |
+9,390
| New | +$243K |
|
89
MindMed
MNMD
$689M
| $238K | 0.18% |
+36,642
| New | +$238K |
|
90
Trevi Therapeutics
TRVI
$871M
| $234K | 0.17% |
42,788
+1,384
| +3% | +$7.57K |
|
91
Intel
INTC
$105B
| $224K | 0.17% |
10,000
| – | – |
|
92
Terns Pharmaceuticals
TERN
$651M
| $223K | 0.17% |
59,797
+46,990
| +367% | +$175K |
|
93
89bio
ETNB
$1.37B
| $222K | 0.16% |
22,618
-30,606
| -58% | -$301K |
|
94
Zillow
Z
$20.2B
| $215K | 0.16% |
+3,071
| New | +$215K |
|
95
Veritex Holdings
VBTX
$1.86B
| $208K | 0.15% |
+7,980
| New | +$208K |
|
96
Northeast Bank
NBN
$930M
| $208K | 0.15% |
+2,338
| New | +$208K |
|
97
scPharmaceuticals
SCPH
$296M
| $191K | 0.14% |
+50,107
| New | +$191K |
|
|
SLSR
98
Solaris Resources
SLSR
$880M
| $186K | 0.14% |
40,656
-1,156
| -3% | -$5.29K |
|
|
CLYM
99
Climb Bio, Inc. Common Stock
CLYM
$151M
| $180K | 0.13% |
145,179
-581
| -0.4% | -$720 |
|
100
VistaGen Therapeutics
VTGN
$113M
| $174K | 0.13% |
86,819
-34,832
| -29% | -$69.7K |
|